NO864442L - Mutantkodende sekvens. - Google Patents

Mutantkodende sekvens.

Info

Publication number
NO864442L
NO864442L NO864442A NO864442A NO864442L NO 864442 L NO864442 L NO 864442L NO 864442 A NO864442 A NO 864442A NO 864442 A NO864442 A NO 864442A NO 864442 L NO864442 L NO 864442L
Authority
NO
Norway
Prior art keywords
aat
coding sequence
polypeptide
mutant
expression
Prior art date
Application number
NO864442A
Other languages
English (en)
Norwegian (no)
Other versions
NO864442D0 (no
Inventor
Alex Joseph Bollen
Albert Alfred Herzog
Hanne Ranche Johansen
Martin Rosenberg
Allan Richard Shatzman
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO864442D0 publication Critical patent/NO864442D0/no
Publication of NO864442L publication Critical patent/NO864442L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO864442A 1985-11-08 1986-11-07 Mutantkodende sekvens. NO864442L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79613385A 1985-11-08 1985-11-08

Publications (2)

Publication Number Publication Date
NO864442D0 NO864442D0 (no) 1986-11-07
NO864442L true NO864442L (no) 1987-05-11

Family

ID=25167384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864442A NO864442L (no) 1985-11-08 1986-11-07 Mutantkodende sekvens.

Country Status (15)

Country Link
EP (1) EP0222726A3 (da)
JP (1) JPS62158487A (da)
KR (1) KR870005090A (da)
CN (1) CN86108300A (da)
AU (1) AU6469886A (da)
DK (1) DK531086A (da)
FI (1) FI864518A7 (da)
HU (1) HUT43876A (da)
IL (1) IL80477A0 (da)
NO (1) NO864442L (da)
NZ (1) NZ218148A (da)
PH (1) PH24368A (da)
PT (1) PT83688B (da)
ZA (1) ZA868487B (da)
ZW (1) ZW22286A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1299120C (en) * 1984-10-22 1992-04-21 Glenn Kawasaki Stable dna constructs for expression of alpha-1-antitrypsin
GB8929110D0 (en) * 1989-12-22 1990-02-28 3I Res Expl Ltd Polypeptides and dna encoding therefor
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
CN110092828B (zh) * 2018-01-31 2021-08-24 北京大学 重组突变体α1-抗胰蛋白酶及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
EP0103395A3 (en) * 1982-08-17 1985-05-22 Biogen N.V. Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
EP0114777B1 (fr) * 1983-01-21 1990-08-01 Transgene S.A. Nouveaux vecteurs d'expression et leur application à la préparation d'une protéine ayant l'activité de l'antitrypsine-alpha 1 humaine
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
EP0169114B1 (fr) * 1984-06-19 1991-01-16 Transgene S.A. Dérivés de l'alpha 1-antitrypsine humaine et procédé pour leur préparation
BE901119A (fr) * 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
US4828988A (en) * 1986-05-15 1989-05-09 Smith Kline - Rit Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine

Also Published As

Publication number Publication date
DK531086D0 (da) 1986-11-06
JPS62158487A (ja) 1987-07-14
FI864518A0 (fi) 1986-11-06
ZW22286A1 (en) 1987-06-03
DK531086A (da) 1987-05-09
PT83688A (en) 1986-12-01
AU6469886A (en) 1987-05-14
FI864518L (fi) 1987-05-09
PT83688B (pt) 1989-06-30
EP0222726A3 (en) 1989-02-01
HUT43876A (en) 1987-12-28
PH24368A (en) 1990-06-13
EP0222726A2 (en) 1987-05-20
NZ218148A (en) 1989-06-28
ZA868487B (en) 1987-11-25
FI864518A7 (fi) 1987-05-09
KR870005090A (ko) 1987-06-04
CN86108300A (zh) 1987-07-01
IL80477A0 (en) 1987-02-27
NO864442D0 (no) 1986-11-07

Similar Documents

Publication Publication Date Title
AU596810B2 (en) A bacterial methionine n-terminal peptidase
JP4243104B2 (ja) 重要なタンパク質の細菌培養上清中への分泌のための融合タンパク質
DK174977B1 (da) Humane t-PA-proteiner, deres fremstilling, DNA, hybridvektor og transformeret eukaryot værtscelle indeholdende en DNA-sekvens, som koder for de humane t-PA-proteiner, og farmaceutisk præparat indeholdende et sådant t-PA-protein
EP0205475B1 (en) Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
US5591640A (en) Functional DNA block and plasmid coding for hirudin, transformed yeast, method for preparing hirudin, hirudin obtained and its pharmaceutical use
IE881597L (en) Expression of Human Proapolipoprotein A-I
US5100784A (en) Process for the preparation of mature human serum albumin
US5013662A (en) Bacterial methionine n-terminal peptidase
WO1991018101A1 (en) Process for producing protein
DK175483B1 (da) Enkeltkædehybridplasminogenaktivator, DNA-sekvens, som koder derfor, hybridvektor indeholdende DNA-sekvensen, eukaryotisk værtscelle transformeret med hybridvektoren, fremgangsmåde til fremstilling af enkeltkædehybridplasminogenaktivatoren,......
CA2025070C (en) Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof
US4828988A (en) Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine
US5037744A (en) Process for the microbiological preparation of human serum albumin
US4870017A (en) Bacterial methionine N-terminal peptidase
EP0329693A1 (en) Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
DK175020B1 (da) Fremgangsåde til udtrykkelse og ekstracellulær udskillelse af proteiner i G(-)bakterie, rekombinant DNA-konstruktion og plasmidvektor kodende herfor, samt G(-)bakterie indeholdende disse
NO864442L (no) Mutantkodende sekvens.
CA1300534C (en) Human pancreatic elastase
NO179046B (no) Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator
FI106720B (fi) Fuusioproteiinien valmistus in vitro
GB2143535A (en) Improved plasmid vector and use thereof
JP3005621B2 (ja) リシントキシン
WO1992004444A1 (en) Methods for producing acyloxyacyl hydrolase
JPH01501037A (ja) 有機化合物の又はそれに関連する改良
HU217094B (hu) Eljárás proteázinhibitorok előállítására